Home / FOGHORN THERAPEUTICS INC. (FHTX)

FOGHORN THERAPEUTICS INC. (FHTX) Technical Analysis

Updated: 2026-05-01 03:14 UTC · Last close: 4.75 (-0.21%) · Support: 4.63 · Resistance: 5.11
FOGHORN THERAPEUTICS INC. (FHTX) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬇️ Support
4.63
⬆️ Resistance
5.11
⚠️ Risk Line
losing 4.63 would weaken the current structure.
Quick Read
The next meaningful technical decision is likely to occur between support at 4.63 and resistance at 5.11.
🔺 Technical Setup
RSI(14)
42.3
🎯 Decision Map
The next meaningful technical decision is likely to occur between support at 4.63 and resistance at 5.11. A move through resistance would be needed to materially improve the chart, while a break of support would keep the pressure side dominant. Pattern-based invalidation is near 6.18; losing that area would weaken the active formation considerably.
📊 Technical Summary
FOGHORN THERAPEUTICS INC. (FHTX) closed at 4.75 (-0.21%). Price remains below both the 50-day and 200-day moving averages, which keeps the broader technical backdrop under pressure until stronger recovery signals appear. 20-day momentum is running at -3.06%; price remains inside its roughly 52-week range (3.53–6.68); and ATR14 volatility is elevated at roughly 6.03% of price. RSI(14) stands around 42.3, which keeps the momentum picture broadly balanced. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram is negative and weakening further, which reflects continued downside pressure. The chart is currently flagging Double top. The nearest decision zone is framed by support at 4.63 and resistance at 5.11. A move through resistance would improve the short-term technical tone, while a loss of support would weaken the current structure. Latest fundamentals snapshot: Revenue: 8.15M · Net income: -74.28M · EPS (basic): -0.25. The interactive view adds overlays, pattern context and broader chart structure for deeper review.
💼 Fundamentals Snapshot
Source: sec
Company
FOGHORN THERAPEUTICS INC.
CIK (SEC ID)
0001822462
Shares Out.
56.54M
Revenue
8.15M
Net Income
-74.28M
EPS (Basic)
-0.25
Explore more
Broadcom (AVGO) technical analysisJpmorgan Chase & Co (JPM) technical analysisVisa (V) technical analysisMastercard (MA) technical analysisEli Lilly And Company (LLY) technical analysisUnitedHealth Group (UNH) technical analysisExxon Mobil (XOM) technical analysis
WOI OPEN ADVANCED ANALYSIS WORKSPACE
Note: This is an algorithmic technical snapshot (not financial advice).
FHTX Chart